Literature DB >> 16362706

Preventive non-pharmacological treatment and nitric oxide in chronic migraine.

Irene Ciancarelli1, Maria G Tozzi-Ciancarelli, Caterina Di Massimo, Luigi Olivieri, Antonio Carolei.   

Abstract

In chronic migraine the central sensitisation and the changes of regional cerebral blood flow are mediated by nitric oxide (NO) and oxygen free radicals. Biofeedback is considered a preventive non-pharmacological treatment decreasing migraine attacks. We investigated whether biofeedback effectiveness is related to relaxation processes and its influence on oxidative stress. The Migraine Disability Assessment Score (MIDAS) and serum NO stable metabolites (NO(x)) were evaluated in 20 patients with chronic migraine before and at the end of biofeedback sessions. MIDAS score was lower after biofeedback than that reported before treatment. NO(x) serum levels were higher after biofeedback than those measured before starting treatment. Thus, the effectiveness of biofeedback is related to a muscular relaxation and to its influence on NO bioavailability in patients with chronic migraine.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16362706      PMCID: PMC3452005          DOI: 10.1007/s10194-005-0227-5

Source DB:  PubMed          Journal:  J Headache Pain        ISSN: 1129-2369            Impact factor:   7.277


  4 in total

Review 1.  [Therapy of primary chronic headache: chronic migraine, chronic tension type headache and other forms of daily chronic headache].

Authors:  A Straube; A May; P Kropp; Z Katsarava; G Haag; C Lampl; P S Sándor; H-C Diener; S Evers
Journal:  Schmerz       Date:  2008-10       Impact factor: 1.107

Review 2.  Behavioral therapy for chronic migraine.

Authors:  Francesca Pistoia; Simona Sacco; Antonio Carolei
Journal:  Curr Pain Headache Rep       Date:  2013-01

3.  Vitamin D, Chronic Migraine, and Extracranial Pain: Is There a Link? Data From an Observational Study.

Authors:  Valentina Rebecchi; Daniela Gallo; Lucia Princiotta Cariddi; Eliana Piantanida; Payam Tabaee Damavandi; Federico Carimati; Marco Gallazzi; Alessandro Clemenzi; Paola Banfi; Elisa Candeloro; Maria Laura Tanda; Marco Mauri; Maurizio Versino
Journal:  Front Neurol       Date:  2021-05-13       Impact factor: 4.003

4.  Increased asymmetric dimethylarginine and nitric oxide levels in patients with migraine.

Authors:  Ertugrul Uzar; Osman Evliyaoglu; Gülten Toprak; Abdullah Acar; Yavuz Yucel; Tugba Calisir; Mehmet Ugur Cevik; Nebahat Tasdemir
Journal:  J Headache Pain       Date:  2011-02-27       Impact factor: 7.277

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.